April 22, 2025 11:40–1:00 PM
Great Room
Speakers
David Perryman, JD, Chief Operating Officer at DRIVE Innovations
Dr. Todd Sherer, Associate Vice President for Research Administration at Emory University
Discover the groundbreaking innovations coming out of DRIVE. DRIVE exists to help bridge the gap between scientific discovery to helping patients. Follow the unlikely path to market of the drug MOLNUPIRAVIR, the world’s first oral direct-acting antiviral drug for COVID-19. Initially licensed to DRIVE, who guided it through IND, it was then sublicensed and eventual licensed to Merck, where it became a multi-billion success. Hear how the process generated a dynamic ongoing partnership to develop follow-on drugs of impact.
Sponsors
